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Abstract
The human gut is colonized with a myriad of microbes, with substantial interpersonal variation. This complex
ecosystem is an integral part of the gastrointestinal tract and plays a major role in the maintenance of homeostasis. Its
dysfunction has been correlated to a wide array of diseases, but the understanding of causal mechanisms is hampered
by the limited amount of cultured microbes, poor understanding of phenotypes, and the limited knowledge about
interspecies interactions. Genome-scale metabolic models (GEMs) have been used in many different fields, ranging from
metabolic engineering to the prediction of interspecies interactions. We provide showcase examples for the application
of GEMs for gut microbes and focus on (i) the prediction of minimal, synthetic, or defined media; (ii) the prediction of
possible functions and phenotypes; and (iii) the prediction of interspecies interactions. All three applications are key in
understanding the role of individual species in the gut ecosystem as well as the role of the microbiota as a whole.
Using GEMs in the described fashions has led to designs of minimal growth media, an increased understanding of
microbial phenotypes and their influence on the host immune system, and dietary interventions to improve human
health. Ultimately, an increased understanding of the gut ecosystem will enable targeted interventions in gut microbial
composition to restore homeostasis and appropriate host-microbe crosstalk.
Keywords: Microbiome, Microbiota, Genome-scale metabolic model, Culturing, Minimal media, Phenotype prediction,
Interspecies interactions
Background
Understanding the gut microbiome
The human gut is colonized since birth with complex mi-
crobial communities, mainly consisting of bacteria with mil-
lions of unique genes that show substantial interpersonal
variation in adult life [1]. This complex ecosystem—the gut
microbiome—is an integral part of the gastrointestinal tract
(GIT) and is intrinsically involved in the maintenance of
body homeostasis. Aberrations in the microbial composition
have been correlated to a wide array of diseases, ranging
from obesity to diabetes, and from inflammatory bowel dis-
ease to autism [2, 3]. These correlations have spawned inter-
est in developing strategies to improve human health by
rationally steering this composition and thereby the function
of the gut microbiome [4, 5]. This approach has been greatly
stimulated by the success of transplantations of fecal micro-
biota, which showed that ‘bugs-can-beat-drugs’ in fighting
recurrent Clostridium difficile infections [6]. However,
rationally steering microbiome composition and function
requires a thorough understanding of the causal mecha-
nisms underpinning these correlations. Thus far, this under-
standing has been hampered by (i) the gap between the
number cultured gut bacteria and sequenced gut bacteria,
(ii) the poor phenotypic characterization of the majority of
gut microbes, and (iii) the limited understanding of the in-
teractions of microbes with each other as well as their host.
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As in other areas of research, the deployment of descriptive
and predictive mathematical models has the potential to
provide insights that ultimately enable to overcome these
limitations. In this review, we will discuss the use of
genome-scale constraint-based metabolic models for an in-
creased understanding of the gut microbiome and its role in
gut homeostasis and (dys)function.
Genome-scale metabolic models in gut microbiota
research
Genome-scale metabolic models (GEMs) are mathema-
tical representations of the knowledge on an organism’s
metabolic capacity and have been previously applied in
bacterial systems for a variety of purposes, including the
design of cultivation media, phenotypic characteriza-
tions, metabolic engineering, drug discovery, and to
study interspecies interactions. For an overview of com-
mon GEM applications, we would like to refer to these
reviews [7, 8].
Strong developments in both GEMs and gut micro-
biome research are bound to facilitate moving from cor-
relation studies to gaining mechanistic insights. GEMs
can integrate knowledge on the metabolism of one or
more gut microbes and predict how this metabolic sys-
tem functions in different niches in the gut. The gut
environment includes nutrient gradients both along the
length of the GIT, as well as along the mucosal gradient
and villi, and have strong effects on the microbial func-
tion [9, 10]. GEMs provide a valuable framework for the
integrated study of gut function as they enable the gene-
ration of testable hypotheses that can lead to novel insights
into causal relationships between the gut microbiome and
human health. Considerable progress in these relations has
been obtained with the short chain fatty acids (SCFAs) that
are produced as main bacterial metabolites in the colon, as
illustrated for butyrate, an established functional com-
pound [11, 12]. The impact of SCFAs on metabolic health
has been reviewed recently [13]. In a model system, it was
found that acetate is secreted by Bifidobacterium adoles-
centis L2-32, taken up by Faecalibacterium prausnitzii A2-
165 and used to produce butyrate from sugar. This
enabled the prediction of F. prausnitzii acetate require-
ments for butyrate production and how this relates to its
low abundance in cases of Crohn’s disease [4], showing
how an observed correlation can possibly be explained
mechanistically using GEMs.
In the remainder of this review, we will discuss the use
of GEMs in gut microbiota research and how GEMs can
advance gut research toward the understanding of gut
homeostasis and (dys)function. We will focus on the
metabolic reactions of the microbes in the gut, on their
growth, on their interactions, and on the metabolites
produced. These are either primary products of micro-
bial metabolism or breakdown products of our diets or
host compounds, having a plethora of functions, ranging
from SCFAs that fuel enterocytes and have specific sig-
naling and immune functions, to vitamins and other
host growth-promoting compounds [14]. Most of these
metabolites cannot be easily detected in the human GIT
as these are taken up by the host and processed in the
liver. Since GEMs stochiometrically represent all meta-
bolic reactions in a microbe or microbial community,
such models enable to estimate the production of these
transient metabolites, estimate their distributions within
the global metabolic network, and provide hypotheses
for the metabolic interactions among gut microbes and
of those with their host. Moreover, GEMs are instru-
mental in optimizing growth of GIT microbes in labo-
ratory conditions and hence are relevant for the
production of biomolecules that are involved in host
signaling, such as TLR ligands or specific functional pro-
teins [15, 16]. First, we briefly describe the process of
genome-scale metabolic reconstruction and its implica-
tions for network modeling. Secondly, we describe appli-
cations of GEMs for gut microbiome research that
enable (i) selecting minimal and defined growth media
for previously cultured as well as not yet cultured gut
microbes, (ii) predicting growth and phenotypes of gut
microbes and their influence on health and disease, and
(iii) modeling co-cultures and multispecies interactions
of gut microbes and the human host (Fig. 1).
Genome-scale metabolic reconstruction and network
modeling
The basis of GEM construction is the genome annota-
tion of the microbe of interest since this predicts the en-
zymes a microbe encodes, and thereby provides a list of
chemical reactions the microbe can perform. This list of
chemical reactions forms the draft metabolic model,
which is often far from complete [17]. Typically, there
are missing reactions due to incorrect, missing, or low-
quality annotations, even for well-studied organisms
[18]. Moreover, our knowledge of the biochemical path-
ways is often insufficient, with unknown conversions still
being discovered [19]. These missing reactions—also
called gaps—severely limit the possibilities for GEM ana-
lyses, as parts of the metabolic network are not con-
nected. Therefore, gap-filling algorithms are used to
predict the presence of additional reactions that can be
obtained from reaction databases such as KEGG [20] or
Metacyc [21] and to connect disconnected parts of the
network [17, 22]. Thereby, these algorithms provide hy-
potheses on enzymes that were missed in the genome
annotation. In some cases, a corresponding gene, not
initially annotated as such, is identified and the genome
annotation is improved. In the remaining cases, the reac-
tions become ‘orphan reactions,’ e.g., reactions that are
thought to occur in the microbe based on existing
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pathways of other microbes but that have not been
linked to any genes. The addition of orphan reactions
might lead to erroneous model predictions, but is often
essential to obtain a functioning GEM and facilitates tar-
geted gene identification [17, 22]. Model construction
and gap-filling algorithms have been extensively de-
scribed elsewhere [17, 22, 23].
After gap-filling, GEMs are expected to be able to sus-
tain in silico growth of the modeled organism. Growth is
modeled as the formation of biomass in a complex
organism-specific reaction involving a large number of
biomass precursors such as DNA, RNA, proteins, lipids,
ATP, NADPH, and various small molecules. The use of
biomass precursors in bacterial GEMs has recently been
thoroughly explored resulting in a shortlist of universally
essential, as well as organism-specific biomass precur-
sors [24]. If all of these precursors can be formed in the
right ratios, the GEM predicts that growth is possible.
The most common way to predict growth phenotypes is
through flux balance analysis (FBA) [25]. FBA deter-
mines an optimal flux distribution for the production of
biomass components while adhering to several types of
constraints: (i) mass-balance constraints; the production
and consumption of intracellular metabolites cancels
out, (ii) thermodynamic feasibility constraints; reactions
can only operate in thermodynamically feasible direc-
tions, and (iii) capacity constraints; fluxes through reac-
tions are bounded to biologically feasible ranges.
Capacity constraints are also used to define the medium
conditions by directly defining which metabolites can be
imported. Thereby, GEMs can be easily modified to
simulate growth phenotypes in a wide range of different
experimental conditions.
GEMs are typically evaluated by comparing predicted
growth phenotypes for both wild type and mutant
strains to the available experimental data. This experi-
mental data usually consists of growth measurements
for a large number of media containing different carbon,
nitrogen, phosphorus, and sulphur sources. For the com-
parison, both the experimental data and the GEM pre-
dictions are discretized to the two states ‘growth’ and ‘no
growth.’ This binary discretization leads to two different
types of inconsistencies: (i) growth predicted by the
GEM but not experimentally found, and (ii) growth that
is experimentally validated but not predicted by the
GEM. In the first case, the GEM overestimates the mi-
crobe’s abilities, suggesting it may include reactions that
the microbe cannot perform. In contrast, the other case
suggests that the GEM is missing reactions. This com-
parison can thus be used to evaluate both the annotation
and the gap-filling process that underlie the GEM con-
struction. For example, if the removal of a single reac-
tion from the GEM results in a large improvement of
GEM predictions, this suggests that this reaction was er-
roneously added and should be considered for removal.
This process of using experimental data to find incorrect
GEM predictions and subsequently making changes to
the GEM has also been combined into algorithms, such
as GrowMatch [26], that will make a minimal number of
changes to a GEM while maximizing its coherence to
experimental data.
The established manual GEM reconstruction process
ultimately results in high-quality GEMs, but is extremely
time-consuming [17]. The advent of high throughput
sequencing and concurrent rapid increase in available
biological data warrants a faster approach, which is
Fig. 1 Simplified overview of the use of GEM to increase understanding of the metabolic interactions in the gut microbiome. Individual species
require metabolites (squares) to grow. These metabolites can be predicted by GEMs, which results in medium and growth (rate) prediction (i, top).
The possible solution the bacteria use to metabolize these metabolites can change under different conditions (ii, middle), which leads to altered
interactions between bacteria (iii, bottom)
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provided by the RAVEN toolbox [27] and the Model-
SEED approach [28]. In both cases, the process of geno-
me annotation, draft GEM construction, and gap-filling
has been fully automated, although extensive manual
curation remains necessary to sustain a high quality [27,
28]. This curation process has recently been streamlined
for gut microbes specifically as part of the AGORA
metabolic GEM resource [29]. A distinguishing feature
of the AGORA GEM resource is the semi-automatic
curation of ModelSEED GEMs where corrections that
are manually applied to a single GEM are propagated to
the GEMs of other gut microbes. This semi-automatic
curation both speeds up the curation process and finally
results in more uniform and higher quality GEMs.
Use of GEMs to design defined culture media
The basis of classic microbiology is the ability to culture
bacteria in a pure culture on a well-defined medium.
Such a well-defined medium is required for detailed
metabolic analyses, growth optimization, and finally also
in a feedback loop with the GEM itself to optimize the
metabolic model. Moreover, well-defined media devoid
of animal-derived compounds will be needed when in-
testinal microbes that are therapeutically effective are to
be cultured and used in therapeutic settings. An example
is the recently developed medium for Akkermansia
muciniphila that was used for a human safety study [61].
Finally, obtaining pure cultures is essential for interven-
tion studies to investigate host-microbe interactions and
to use the beneficial bacteria as potential therapeutic mi-
crobes. Pure cultures have been successfully obtained for
over 1000 different gut species [30], which was recently
expanded by high throughput culturing approaches [31,
32]. However, as it has been predicted that there are at
least two to three times more different gut species, a sig-
nificant number of gut microbes remain uncultured and
inaccessible for study in isolation [33]. A number of
known not yet cultured candidates have been listed in a
‘most wanted’ list [34], which highlights the need for
culturing of gut microbes. Among these targets are
Oscillospira spp. that are receiving considerable atten-
tion [35–37]. A major issue in the culturing of these
microbes is the lack of suitable growth media. Growth
media are often based on the ecosystem a microbe nat-
urally occurs in, but the gut is extremely complex with
many different nutrients, highly variable nutrient levels,
and many interspecies interactions. Here, we first de-
scribe the challenges in the use of GEMs for the design
of defined media, and then how GEMs have been suc-
cessfully used for the design of defined media and how
similar approaches can be used to design suitable de-
fined media for not yet cultured bacteria.
There are three main challenges in the use of GEMs
for the design of defined growth media: (i) The in silico
biomass composition is an influential aspect of the GEM
as it defines all metabolites required for growth [24].
The omission of even a single metabolite in this compo-
sition can prevent the GEM from predicting an essential
media supplement. However, the biomass composition
cannot be fully determined in silico and relies on the
availability of organism-specific experimental data. As this
is not available for many gut microbes, automatic model
generation procedures rely on heuristics to estimate the
biomass components that are required for each organism
[28, 29]. We highly recommend evaluating a given bio-
mass composition generated from automatically generated
GEMs according to the guidelines recently set out in a
thorough evaluation of biomass compositions [24] prior
to gap-filling and media design. (ii) The gap-filling step in
GEM construction typically relies on the introduction of
known biochemical reactions to complement the meta-
bolic network of the modeled microbe [22]. In particular,
reactions are often added such that the GEM predicts in
silico growth in a pre-defined medium, which is not di-
rectly suitable if no chemically defined medium is known
for the microbe or if the microbe uses not previously cha-
racterized reactions. Hence, all gap-filling reactions should
be carefully individually inspected and corresponding
genes need to be identified to support the procedure. (iii)
GEMs do not capture the non-linear link between con-
centrations of medium components and the speed with
which microbes can import them. Hence, GEM-based
medium design is limited to predicting which compounds
need to be present and cannot be used to determine opti-
mal concentrations.
Despite these challenges, GEMs have proven to be use-
ful in the design of chemically defined growth media, as
has been shown for the lactic acid bacterium Lactobacillus
plantarum WCFS1 [38]. Lactic acid bacteria are impor-
tant in many industrial food processes and some are
marketed as probiotics [39]. Therefore, the GEMs of lactic
acid bacteria are used to study their metabolic capa-
bilities and behavior in fermentation processes [40, 41],
as well as their probiotic functions [42, 43]. The GEM
of L. plantarum WCFS1 was automatically constructed
based on its genome sequence and subsequently exten-
sively manually curated [38, 44]. The GEM was then
used to predict the essentiality of 36 compounds in a
chemically defined growth medium. The GEM predic-
tions were correct for 29/36 (81%) of the compounds,
but were incorrect for the vitamins folate, thiamine,
and vitamin B6, as well as for the amino acids arginine,
glutamate, isoleucine, and tryptophan. The incorrect
predictions pinpointed errors in both the GEM con-
struction process and in the experimental procedures,
and also pinpointed distinct metabolic features of L.
plantarum WCFS1, for example (i) the incomplete fo-
late biosynthesis pathway in the GEM was in part due
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to a missing EC number for a correctly annotated gene,
as well as no reactions in Metacyc for another EC num-
ber. (ii) The GEM lacked a complete isoleucine biosyn-
thesis pathway, but growth was observed in the
isoleucine omission experiment. This turned out to be
a result of isoleucine contamination in the other amino
acids. (iii) A missing reaction for thiamine biosynthesis
was assigned to a gene involved in molybdopterin bio-
synthesis. In Enterobacteria, these reactions are carried
out by two paralogs, but it appears that both reactions
are carried out by a single enzyme in L. plantarum
[38]. These results clearly illustrate how a GEM-driven
systematic evaluation of medium compositions can in-
crease the understanding of a microbe’s metabolism.
A GEM of a different lactic acid bacterium, Lactococcus
lactis IL1403, was constructed and used to remove all
non-essential metabolites from a rich medium in order to
design a minimal medium for physiological studies [45].
This exercise in medium design not only resulted in a
minimal medium but also allowed for careful comparisons
between in silico predictions and experimental data to
understand their differences. The GEM predicted that
arginine, methionine, and valine are essential for growth,
and that either glutamate or glutamine is required addi-
tionally. However, recent single amino acid omission
experiments have led to the conclusion that arginine, as-
paragine, histidine, methionine, serine, isoleucine, leucine,
and valine are essential medium components for L. lactis,
and that glutamate and glutamine are not [46]. At first
glance, this might incorrectly seem like poor performance
by the GEM. However, the agreements and disagreements
between predictions and experiments can be summarized
in three points: (i) they agree on the essentiality of argi-
nine, methionine, valine, and the non-essentiality of the
ten amino acids not previously mentioned; (ii) they do not
evaluate glutamate and glutamine in the same man-
ner—the GEM predicts that one of them is required,
whereas the experiment indicates that either one can be
omitted, but that glutamine cannot be omitted if the con-
centration of glutamate is additionally reduced to 10% of
the normal concentration; and (iii) they disagree on the
essentiality of asparagine, histidine, isoleucine, leucine,
and serine, but also disagree on the meaning of ‘essential.’
In the L. lactis IL1403 GEM, a compound was essential if
its omission reduced the specific growth rate below 0.01/
h. In the omission experiment, a compound was consi-
dered essential if the final OD dropped below 40% of the
final OD in the rich medium. This introduces a certain
level of ambiguity and, for example, if the experimental
threshold would instead be at 20%, asparagine and serine
would not have been considered essential.
The ability to culture pathogens and probiotics is im-
portant to study them in isolation and to determine their
role in the gut microbiome. Therefore, a GEM was used
to design a minimal growth medium for Staphylococcus
aureus N315, a pathogen that frequently infects hospita-
lized patients [47]. The GEM predicted that several
amino acids were essential, but in vivo experiments indi-
cated otherwise. Later on, an updated GEM predicted
that S. aureus N315 has no intrinsic auxotrophies for
amino acids, but that some particular isolates do require
some amino acids [48]. This discrepancy between the
updated GEM and the experimental results for the iso-
lates was explained by the repression of amino acid syn-
thesizing genes. The repression could be relieved by
progressively eliminating the amino acids from the
medium, supporting the GEM prediction that S. aureus
can indeed synthesize these amino acids. This study
showed how a GEM can aid in omitting nutrients from
a known defined medium.
These three case studies show that GEMs are a good
starting point for designing minimal media. In fact, the abi-
lity of GEMs to design growth media was recently empha-
sized by the development of the Minimal Environmental
TOol (MENTO) [49]. MENTO predicts the minimal
medium requirements for an organism based on its GEM,
and was used to study broad nutritional trends in over
2500 automatically generated ModelSEED [28] models. For
three well-characterized organisms, the predictions based
on the ModelSEED models were also compared to the pre-
dictions based on manually curated models. The com-
parison indicated that the ModelSEED models are more
pessimistic growth predictors, but have a similar accuracy
[49]. Nonetheless, the authors indicate that while the
ModelSEED models are suitable for studying broad nu-
tritional trends, one should be careful in interpreting results
for any specific organism. A ModelSEED model thus re-
quires manual curation before using it to predict suitable
minimal growth media.
Such a manually curated ModelSEED GEM was recently
used for minimal medium design for F. prausnitzii, a
prevalent and potential beneficial gut microbe that is com-
monly grown on the chemically undefined YCFAG
medium [50]. The automatically generated ModelSEED
GEM was first manually curated such that it correctly
captured the known biochemistry and physiology of F.
prausnitzii. This curation involved changing the biomass
reaction, updating reaction directionalities, adding species-
specific pathways, and filling gaps. The curated GEM was
then used to predict a chemically defined growth medium
called CDM1. CDM1 did, however, not facilitate in vitro
growth and was subsequently supplemented with addi-
tional nutrients to form an extended medium CDM2,
which did facilitate in vitro growth. The researchers then
used LC-MS to identify what metabolites in CDM2 are net
consumed, and what metabolites are net produced. The
metabolite consumption and production data was then
used to improve the GEM and the corresponding genome
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annotation. Ultimately, the researchers were able to design
a refined and chemically defined medium CDM3 that faci-
litated both in silico and in vitro growth, albeit that growth
was still rather poor and unreliable [50].
The requirement for manual curation of ModelSEED
[28] GEMs prior to media design has been substantially
reduced due to the presence of 773 semi-automatically
curated GEMs of relevant gut microbes [30, 51] in the
AGORA GEM resource [29]. These GEMs have been
curated collectively such that any issues addressed in
one GEM are also directly addressed in others. Although
further microbe-specific manual curation may still be re-
quired for many microbes, some AGORA GEMs may
also be directly suitable for media design. As a showcase,
the AGORA GEM of Bacteroides caccae ATCC 34185
was successfully used to design the first chemically de-
fined medium supporting in vitro growth for this gut
microbe [29].
Metagenomic studies [52] and single-cell genomics
[53, 54] of gut bacteria have already yielded genomes
that could be used to create draft GEMs. However, the
available biochemical information to turn draft GEMs
into functional GEMs for uncultured bacteria is limited.
To gain more insight in secreted metabolites and avail-
able nutrients in the gut, imaging mass spectrometry
can be applied [55]. These uptake and secretion pat-
terns can be incorporated into GEMs. We encourage
the use of GEMs to predict minimal or defined media
on which the microbes of interest can be cultured.
Combined with additional ecological and genomic
markers, such as temperature, antibiotic resistance,
and spore formation, it should be possible to culture
more bacterial species (Fig. 2). The next steps are in
predicting how varying environments result in differ-
ent phenotypes.
Phenotype prediction
Most microbes have versatile and complex metabolic path-
ways. Often, many alternative pathways are available for the
conversion of the available substrate to all biomass compo-
nents. GEMs can be used to explore all possible phenotypes
for a wild type or mutant strain in a given environment. In
addition, GEMs can be used to interpret experimental data
that is difficult to directly connect to metabolic rates, such
as transcriptomics and proteomics data [56]. GEMs, which
are ultimately based on genotypes, are thus a means to ex-
plore possible phenotypes in a wide range of different ex-
perimental conditions. The ability to predict how different
microbial phenotypes result from different environments
can ultimately have consequences for human health. For
example, GEMs may be able to identify the conditions
under which conditional pathogens become pathogenic
[57], or, in contrast, when therapeutic bacteria or probio-
tics may convey their beneficial properties [42, 58].
A main challenge in the use of GEMs for the predic-
tion of phenotypes of gut microbes is that these models
are—traditionally—restricted to metabolic activities.
They do not explicitly include regulation nor the synthe-
sis of mRNAs or individual proteins. Hence, GEMs can
accurately predict growth phenotypes that are related to
the optimal conversion of substrates to biomass compo-
nents [59], but do not directly predict the synthesis of
secondary metabolites and proteins involved in crucial
processes such as microbe-microbe signaling, microbe-
host communication [60, 61], and inflammation [14].
Such predictions rely on the integration of ~omics data
or regulatory networks, as highlighted by several of the
following examples.
GEM-driven exploration of the metabolic capacities
of pathogens has been explanatory for pathogenic
phenotypes. For example, a GEM was used to predict
virulence of Salmonella in a mouse model system.
The GEM describes a very versatile metabolism that
enables Salmonella to utilize 31 host nutrients, allo-
wing it to grow fast within the host cell. The GEM
predicted the pathogenicity of phenotypes and was ac-
curate in 92% of the cases [62]. In addition, it was
found that the metabolic capabilities of Salmonella
show similarities in host dependency for growth substrates
and biosynthesis to other pathogens. Like Salmonella,
other pathogens are also capable of degrading purine
nucleosides, pyrimidine nucleosides, fatty acids, glycerol,
arginine, N-acetylglucosamine, glucose, and gluconate.
Similarly, it was hypothesized that comparisons of meta-
bolic patterns between Pseudomonas aeruginosa and non-
pathogenic relatives could yield insight into opportunistic
pathogenic phenotypes of this species [57], as has later
been done successfully for Burkholderia species [63]. The
metabolic model for the pathogenic P. aeruginosa also
showed a versatile metabolic pattern and accounted for
virulence inducing pathways, such as exopolysaccharide
alginate synthesis [64].
In more recent research, highly quantitative proteo-
mics and metabolic measurements were used to impose
pH-dependent constraints on the GEM of Enterococcus
faecalis, a human gut pathogen [65]. The pH-dependent
constrained GEM accurately predicted growth rate, pro-
ton pump activity by ATPase, and a metabolic shift from
mixed acid fermentation to homolactic fermentation.
However, discrepancies were found between expression
of lactate dehydrogenase and lactate production, which
emphasized that constrains based on solely proteomic
measurements are not sufficient for an accurate pheno-
type prediction.
Transcriptomics and proteomics experiments aim to
discover what an organism is doing, but the data is often
difficult to analyze because there are no one-to-one rela-
tionships between expression levels, protein quantities,
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enzyme activities, and fluxes [66, 67]. GEMs can aid in
elucidating the metabolic activities from these data by
visualizing the data on a metabolic map or by predicting
metabolic fluxes [68–71]. For example, transcriptomics
data of two strains of Lactobacillus reuteri, with poten-
tially opposite effects on the human immune system,
were analyzed by visualizing the data on two GEMs. The
analysis revealed that both strains produce vitamins, es-
sential amino acids, and mucosal binding proteins, but
that they differed in their production of potential in-
ducers of tumor necrosis factor [42]. The prediction of
metabolic fluxes from ~omics data relies on the concept
that, on average, gene expression levels are a proxy for
fluxes. The GEM then predicts a flux distribution that
matches the trends in the expression data, while accoun-
ting for mass balance, thermodynamics, and capacity con-
straints. Several such methods have been developed in the
last few years, and have been extensively summarized and
evaluated recently [71]. The evaluation did not result in a
clear best-performing method, and none of the methods
actually outperforms parsimonious FBA [59], which does
not require any ~omics data as input. However, the eva-
luation conditions were limited to minimal media where
the optimization of the conversion of substrates to bio-
mass seems a suitable growth strategy. It remains to be
seen how these various methods compare when microbes
actively synthesize secondary metabolites in situ or in
rich media.
A different approach to find out what an organism is
doing, rather than what it can do, is by combining
GEMs with other models, such as regulatory networks
[72–74]. The regulatory networks of well-studied species
such as Escherichia coli, Mycobacterium tuberculosis,
and Mycoplasma genitalium have been elucidated and
incorporated in metabolic models [75–78]. Based on
these model organisms, attempts have been made to
automate the incorporation of regulatory networks into
GEMs [79], also especially aiming at less well-
characterized species [78]. These models incorporate the
influence of environmental factors on the behavior of
the modeled organism, which may be extremely relevant
for microbes residing in a dynamic environment such as
the human gut.
These examples show how GEMs can be used to explore
possible phenotypes, and to predict actual phenotypes
based on ~omics data or regulatory models. However, we
highlight the need for a thorough evaluation on methods
for the integration of ~omics data and regulatory networks
with GEMs to predict the phenotypes of gut bacteria in
vitro and ultimately in vivo. This will be an important
stepping-stone in predicting the role of bacteria under
different gastrointestinal conditions, on which also other
microbial species have a big influence.
GEM predictions on interspecies interactions
Within the gut microbiome, there are numerous microbial
interactions and networks. Three types of simple multispe-
cies interactions have been described and modeled before:
mutualism, commensalism, competition, and neutralism
[80–82]. GIT-colonizing microbial species often depend
Fig. 2 Suggested cultivation strategy. The initial cultivation strategy of a microbe can be optimized by thorough analysis of its genome and
isolation conditions. The genome contains information on metabolic pathways, as represented in GEMs, that inform on auxotrophies and
suitable carbon, nitrogen, and sulphur sources. In addition, the genome annotation can reveal additional considerations such as antibiotic
or bile resistance, or the ability to form spores. The isolation condition of a microbe, for example the human gut, provides information on
suitable environmental conditions such as temperature, pH, and ion strength
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on each other for growth signals and substrates or com-
pete for the metabolites, thus this ecosystem is ideal for
the modeling of interspecies interactions and using inter-
species interactions predictions to gain a mechanistic
insight into this ecosystem [83, 84]. Interactions between
microbes have been modeled on different phylogenetic
levels, ranging from strains [85] to species [86, 87] and
ecosystem communities [88]. The challenges in multispe-
cies modeling are briefly described below, followed by ex-
amples of successful GEM-based multispecies modeling
approaches that are also summarized in Fig. 3.
Multispecies modeling using GEMs is complicated
through the aforementioned phenotype prediction
challenge regarding secondary metabolites, but also by
two other challenges: (i) the vast majority of GEM ana-
lysis methods rely on a steady-state assumption, but
microbial interactions via signaling molecules are in-
herently dynamic. (ii) Flux prediction methods are
based on computational optimization with regards to a
single metabolic goal, usually the maximization of bio-
mass production; a reasonable goal for an individual
microbial species. However, when multiple microbes
are modeled simultaneously, it is not a reasonable assump-
tion that all work together to maximize total biomass
production. The examples discussed hereafter provide a
rough overview of different approaches that have been
taken to minimize or circumvent these issues.
The pioneering work in GEM-based multispecies mo-
deling was directly combining two GEMs for the mu-
tualistic bacterium Desulfovibrio vulgaris and archaeon
Methanococcus maripaludis S2 into a single model with a
shared extracellular environment [89]. In this ecologically
relevant syntrophic relationship, D. vulgaris ferments
lactate, and M. maripaludis consumes the fermentation
products formate, dihydrogen, and acetate. In this work,
the aforementioned issue on optimizing for biomass pro-
duction was evaluated by applying distinct weights to the
different types of biomass. In other words, the mathema-
tical optimization would prioritize one type of biomass
over the other in order to explore how this would affect
overall flux predictions. The predicted biomass production
for D. vulgaris was practically independent of the relative
weights, whereas the M. maripaludis biomass production
increased if it received higher weights. This is due to the
sequential nature of the interaction between these bac-
teria, where D. vulgaris effectively ‘feeds’ M. maripaludis.
However, this approach is not suitable if the community
members exhibit cross-feeding or substrate competition.
A similar approach was taken to identify media that
stimulate commensal or mutualistic relationships be-
tween each possible pair of seven well-known microbes
[81]. This number was rapidly expanded to 118 species
coupled in 6.903 pairs driven by automated curation of
over a hundred GEMs [82]. The latter study not only
focused on cooperation but also specifically on identify-
ing media that induce competition between pairs of
microbes. It was found that competition was generally
‘won’ by species that grew fast on versatile media, such
as E. coli, while cooperation was more evident in Clostridia
species that were able to degrade lignin and cellulose,
which releases free sugars to other bacteria. This type of
macromolecule degradation is highly important in degra-
dation of host dietary compounds and thus directly relates
to gut health.
Instead of looking into the details of the interactions
between a few species, GEMs have also been used to
elucidate general properties of the co-occurrence of mi-
crobes. Specifically, there are two main mechanisms
Fig. 3 Modes of interspecies interactions as modeled before. Pairwise interactions only account for two species to share metabolites. Multispecies
models allow sharing of metabolites between more than two species. Microbiota-host interaction models lump all the microbial species
into one meta-model and model the interaction with the host. Microbe-microbe and microbiota-host interactions are multilevel models
that take into account microbial interactions and interactions with the host
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driving species co-occurrence: (i) habitat filtering: mi-
crobes occupy a similar nutritional niche and compete,
and (ii) species assortment: microbes have complemen-
tary metabolisms and cooperate. A recent study aimed
to identify which of these two mechanisms is the driving
force behind the co-occurrence of microbes in the hu-
man gut [88]. Therefore, they automatically generated
154 GEMs based on KEGG [20, 90] for gut microbes
whose co-occurrences were determined based on a gut
metagenome dataset containing measurements from 124
individuals. These GEMs were used to determine meta-
bolic competition and complementarity indices between
each pair of species based on network topology, thereby
circumventing the need for optimization based on an
ambiguous multispecies metabolic goal. As the species
co-occurrence was best explained via the metabolic
competition index, the authors concluded that habitat
filtering is the main driving force behind species co-
occurrence in the human gut. In another recent study,
GEMs were used to study species co-occurrence based
on 261 microbial species in 1297 communities from di-
verse habitats [91]. The GEMs were used to calculate
both the resource competition and interaction potential
within these communities based on network topology.
Resource competition was significantly higher in the
1297 communities versus random assemblies, indicating
that habitat filtering was again identified as the main
driving force behind community composition. However,
there were also 7221 sub-communities of up to 4 co-
occurring species within the larger communities. Within
these sub-communities, the interaction potential—defined
as the difference in minimal number of metabolites
required for growth between a non-interacting and a co-
operating community—was significantly higher than in
full communities and random assemblies.
In order to understand how gut communities form
and change, it is also important to consider spatial
and temporal effects. The novel modeling framework
COMETS [92]—Computation of Microbial Ecosystems
in Time and Space—simulates multiple GEMs on a
lattice over time using dynamic FBA [93], which is based
on simulating dynamics using successive steady-state
optimizations. COMETS does not require any prior in-
formation on how the modeled microbes interact, but
nonetheless captures interesting and non-intuitive spa-
tiotemporal dynamics of multispecies interactions. For ex-
ample, it correctly predicted that the slowest-growing
microbe of a three-species ecosystem would also ultima-
tely be the most-prevalent one, and that the growth rate
of a colony with a mutualistic partner can be improved by
placing a competing colony in between them. COMETS
has also been used to study how robust competing and
mutualistic interactions are to genetic perturbations.
Specifically, it has been possible to predict the effects of
gene knockouts on a synthetic community of E. coli and
Salmonella enterica [94] on competition-inducing and
mutualism-inducing growth media [95]. Interestingly, the
community was more robust to genetic perturbations in
E. coli under cooperative conditions, but more robust to
genetic perturbations in S. enterica under competing
conditions [95]. These results highlight that GEMs can
mechanistically explain the intriguing interactions of mul-
tispecies interactions.
A conceptually similar framework is BacArena [96].
BacArena also uses a dynamic form of FBA simulations
to model microbes over time, but simulates individual
microbes across a 2D grid [96] rather than microbial
communities on a lattice as in COMETS [92]. Of par-
ticular interest is the application of BacArena to the
seven species SIHUMI community representative of a
simplified human gut [97]. Initial simulations excluding
glycan production in the lumen resulted in a community
dominated by E. coli. However, as a mucus glycan gra-
dient was imposed using diffusion on the 2D grid, the
glycan-degrading Bacteroides thetaiotaomicron became
dominant in the mucosal layer, while the lumen repre-
sented a more varied community still dominated by E. coli.
A multispecies interaction of particular interest is the
interaction between gut microbes and their host. The
host is not only an important environmental factor for
gut microbes, but is also metabolically active itself. Addi-
tionally, host behavior such as diet intake has a great
and reproducible influence on the microbiota compo-
sition [98]. GEMs have been created for hosts of particu-
lar interest, such as mouse [99] and human [100], and
have even been trimmed down to tissue-specific GEMs,
including a GEM for colon-derived tissue [101]. The hu-
man Recon 2.04 GEM was adapted to be not only tissue
specific but context specific as well. Transcriptome data
obtained from inflamed mucosal tissue in inflammatory
bowel disease (IBD) data was used to generate new
GEMs [102]. Subsequent combination of this data with
bacterial expression data showed uncoupling of host-
microbe metabolic interactions in IBD patients. The mouse
GEM [99] was recently used to study how different diets
and the presence of the gut microbe B. thetaiotaomicron
affect its metabolism [50]. A B. thetaiotaomicron model
was constructed using ModelSEED [28] and, after manual
curation, was linked to the mouse GEM via a shared
lumen compartment. Although a single microbe is not
directly representative of the gut community, the com-
bined GEM mechanistically explained how both organisms
benefit from the mutualism, correctly predicted how the
interaction affects biofluid metabolome composition, and
even described how gut microbes can rescue hosts with
lethal gene deletions [50].
Host-microbe interactions have also been modeled
using a single ‘supra-organism model’ [84] to represent
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all gut microbes simultaneously, thereby also avoiding
optimization-related issues with multiple microbial bio-
mass types. These GEMs do not focus on individual
microbes or their interactions, but rather on the inter-
action of the community with the environment or host.
Such a GEM was used together with metagenomics data
to study how host-microbe interactions differ in case of
obesity or IBD [103]. This revealed a differential expression
of enzyme groups expressed by the complete microbiota
between diseased and healthy people, without investigating
the roles of individual species or their interactions. The
differences were found in the upregulation of membrane
transport and downregulation of vitamin metabolism,
nucleotide metabolism, and transcription. This study sug-
gests that the differences in enzyme expression originate
from an altered interaction between the microbes and their
environment. They are the result of a change in the envi-
ronment of the bacteria and do not come from a change in
core metabolic processes. By combining previous ap-
proaches of modeling interspecies interactions and consi-
dering the whole microbiota as one entity, a predictive tool
for dietary interventions was created [104]. The tool,
CASINO—Community And Systems-level Interactive and
Optimization—predicts dietary interventions based on in-
teractions between the host, the microbiota, and the ap-
plied diet. CASINO was used to model the interactions of
four microbes in two synthetic communities that differed
by a single microbe. It correctly predicted the produced
metabolites, including essential amino acids, and the con-
tribution of each species to the production of each meta-
bolite. CASINO was then used to predict the impact of a
dietary intervention in 44 individuals, based on relative
abundances of the most prevalent microbes in each indi-
vidual before and after the intervention. The predicted
production of SCFAs and amino acids mostly matched the
in vivo measurements. Finally, CASINO was used to
design a beneficial diet for subjects with a poor microbiota
composition [104].
The use of GEMs to predict multispecies interactions
and to study the influence of perturbations in environ-
mental factors and communities is a valuable asset in
microbiota function prediction. In this way, it can be
predicted how individual species contribute to healthy
and diseased conditions. The increase in tools for the
prediction of multispecies interactions highlights the im-
portance of this application. Moreover, these predictions
were instrumental in the prediction of diets to improve
the metabolic function of gut microbiota [104]. Ulti-
mately, this research will lead to increased understan-
ding of the interactions of the gut microbiota and its
host, and on its role in gut homeostasis and (dys)func-
tion, and it will ultimately pave to way to improve
human health using specific gut microbes or dietary
interventions.
Conclusion and perspectives
After a few decades of characterizing gut microbiota
composition many gut microbes have been sequenced
[1, 105]. Over 200 of these genome sequences have been
used to generate GEMs, in most cases by automated
tools [21, 28]. These GEMs have been used to predict
growth phenotypes of single microbes and communities
in laboratory and in vivo settings.
Here, we reviewed three ways in which GEMs contri-
bute in elucidating gut microbiome function. We de-
scribed how GEMs are used to (i) culture bacteria, (ii)
predict bacterial phenotypes under changing conditions,
and (iii) study the interactions both among the bacterial
species and with their host.
We have shown that recent advances in automated
generation of GEMs [28, 29], single-cell genomics [106],
metagenomics [1, 107], and metatranscriptomics [108–
110] can increase the availability and accuracy of GEMs.
Metagenomics as well as single-cell genomics will yield
more genome sequences of microbes that can be used for
generating GEMs. Moreover, developments in single mol-
ecule sequencing will allow for closed genomes that are in
the end the golden standard to be used for generating
GEMs. These GEMs will contribute in understanding how
both uncultured and cultured bacteria live and behave in
complex ecosystems [83]. In vivo or in vitro validation of
GEM predictions and subsequent GEM updates remain
key in improving GEM quality and ultimately understand-
ing the complex gut ecosystem.
GEMs allow understanding why species are present
and what they do, instead of who they are, as was the
focus in the last decades. We expect that GEMs will
contribute to elucidate the mechanisms behind known
probiotics, as well as in identifying new probiotics, and
understanding the role of different bacteria in complex
ecosystems. Ultimately, GEMs can contribute to the de-
sign of controlled interventions that steer gut compo-
sition and activity to improve human health.
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